Financial Data and Key Metrics Changes - In Q1 2025, the company's revenue was $20.5 million, representing a 42% year-over-year growth, with a gross margin of 88% [5][24][25] - The company has maintained steady growth over the past eight to nine quarters, with no quarter showing lower revenue than the previous one [24] Business Line Data and Key Metrics Changes - The business model consists of 25% revenue from SaaS (subscription fees for the algorithm) and 75% from disposable headbands used for EEG monitoring, indicating a strong recurring revenue stream [25][27] - The company is currently focused on the seizure management market, which has a total addressable market (TAM) of $2 billion in the US [4][27] Market Data and Key Metrics Changes - The company currently holds only 2-3% of the US seizure detection market, indicating significant growth potential in the coming years [27] - The company is expanding its product offerings to include pediatric patients, having received FDA clearance for its seizure detection algorithm for ages one and older [28][29] Company Strategy and Development Direction - The company aims to make EEG a new vital sign in ICU settings, expanding its applications beyond seizure detection to include delirium and stroke triage [30][31] - The company is investing in its future pipeline, including ongoing studies for stroke detection and regulatory pathways for delirium detection [31] Management's Comments on Operating Environment and Future Outlook - Management emphasized the importance of early detection and treatment in improving patient outcomes, particularly in acute care settings [11][12] - The company is focused on addressing unmet clinical needs in the acute care market, particularly for seizure management [3][4] Other Important Information - The company has a strong pipeline involving EEG signals and AI for indications beyond seizure management [4] - The company has published evidence showing significant reductions in length of stay and over-administration of anesthesia medication due to its technology [22] Q&A Session Summary Question: What is the company's growth strategy in the seizure detection market? - The company plans to maintain a laser focus on the seizure management market in the US, which has a significant growth opportunity given its current market share [27] Question: How does the company plan to expand its product offerings? - The company is working on expanding its seizure detection algorithm to younger populations and is also exploring applications for delirium and stroke detection [28][30]
CeriBell (CBLL) 2025 Conference Transcript